PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody

Published:2019-06-28 Issue:1 Volume:61 Page:117-122
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Lv Gaochao,Sun Xiaorong,Qiu Ling,Sun Yan,Li Ke,Liu Qingzhu,Zhao Qi,Qin Songbing,Lin Jianguo

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference29 articles.

1. Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy

2. Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway

3. A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now

4. Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade;Zhang;Cell Discov.,2017

5. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activatable near-infrared fluorescence and chemical exchange saturation transfer MRI multimodal imaging probe for tumor detection in vitro and in vivo;Sensors and Actuators B: Chemical;2024-08

2. Peptide-based immuno-PET/CT monitoring of dynamic PD-L1 expression during glioblastoma radiotherapy;Journal of Pharmaceutical Analysis;2024-08

3. Navigating the landscape of PD-1/PD-L1 imaging tracers: from challenges to opportunities;Frontiers in Medicine;2024-06-07

4. Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4–1BB;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-11

5. The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook;Journal of Nuclear Medicine;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3